Japanese encephalitis is the leading cause of vaccine-preventable encephalitis in Asia.4
Many countries include JE vaccination as a part of a national immunization schedule.5
Up to 20,400 people die from JE every year.6,7
More than one-third of people who traveled to Asia and developed JE were on short-term trips.8
Up to 50% of JE survivors suffer from neurological, cognitive, and/or physical disabilities
About 30% of those who experience symptoms die
Only 19% of symptomatic patients fully recover
Culex, particularly Culex tritaeniorhynchus
Biting habits:
Most common:
Other:
None
Protective measures in accordance with CDC recommendations
References: 1. Japanese encephalitis. National Health Service. Updated February 1, 2022. Accessed March 13, 2023. https://www.nhs.uk/conditions/japanese-encephalitis/ 2. Connor BA, Bunn WB. The changing risk of Japanese encephalitis for business travelers. Workplace Health & Safety. 2015;63(12):568. 3. Japanese encephalitis (JEV). Australian government. Department of Health and Aged Care. Updated February 28, 2023. Accessed March 13, 2023. https://www.health.gov.au/health-alerts/japanese-encephalitis-virus-jev/japanese-encephalitis-virus-jev 4. Japanese encephalitis virus. Centers for Disease Control and Prevention. Updated December 7, 2022. Accessed March 13, 2023. https://www.cdc.gov/japaneseencephalitis/index.html 5. Vaccination schedule for Japanese encephalitis. World Health Organization. Accessed March 13, 2023. https://immunizationdata.who.int/pages/schedule-by-disease/japenc.html 6. Japanese encephalitis. World Health Organization. Updated May 9, 2019. Accessed March 13, 2023. https://www.who.int/news-room/fact-sheets/detail/japanese-encephalitis 7. Singh LS, Singh HL, Thokchom L, et al. A descriptive study on prevalence pattern of Japanese encephalitis in State of Manipur. Indian J Med Microbiol. 2019;37(2):235-240. doi:10.4103/ijmm.IJMM_18_180 8. Pavli A, Maltezou HC. Travel-acquired Japanese encephalitis and vaccination considerations. J Infect Dev Ctries. 2015;9(9):917-924. doi:10.3855/jidc.5108 9. Hills SL, Walter EB, Atmar RL, Fischer M. Japanese encephalitis vaccine: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2019;68(2):1–33. doi:10.15585/mmwr.rr6802a1 10. Solomon T, Dung NM, Kneen R, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002;125(Pt 5):1084-1093. doi:10.1093/brain/awf116 11. Transmission of Japanese encephalitis virus. Japanese encephalitis virus. Centers for Disease Control and Prevention. Updated December 7, 2022. Accessed March 13, 2023. https://www.cdc.gov/japaneseencephalitis/transmission/index.html 12. Mosquito bite prevention (United States). Centers for Disease Control and Prevention. October 13, 2016. Accessed March 13, 2023. https://www.cdc.gov/chikungunya/pdfs/fs_mosquito_bite_prevention_us.pdf 13. Symptoms & treatment. Japanese encephalitis virus. Centers for Disease Control and Prevention. Updated October 13, 2022. Accessed March 13, 2023. https://www.cdc.gov/japaneseencephalitis/symptoms/index.html 14. Clinical and laboratory evaluation. Japanese encephalitis virus. Centers for Disease Control and Prevention. Updated February 8, 2019. Accessed March 13, 2023. https://www.cdc.gov/japaneseencephalitis/healthcareproviders/healthcareproviders-clinlabeval.html 15. Prevention. Japanese encephalitis virus. Centers for Disease Control and Prevention. Updated December 7, 2020. Accessed March 13, 2023. https://www.cdc.gov/japaneseencephalitis/prevention/index.html